Form D · Biotechnology
PanTher Therapeutics, Inc.
Austin, TX · CIK 0001644045
Offering snapshot reported Apr 3, 2025 · SEC filing
- Reported sold
- $3.02M Offering amount: $5M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 3, 2025 | Initial | $3,021,707 | No comparison | 26 | SEC filing |
| Dec 18, 2023 | Initial | $2,676,030 | No comparison | 28 | SEC filing |
| Dec 19, 2022 | Initial | $1,261,500 | No comparison | 15 | SEC filing |
| Jun 24, 2022 | Initial | $1,061,000 | No comparison | 17 | SEC filing |
| Jun 2, 2021 | Amendment | $7,334,474 | No comparison | Not reported | SEC filing |
| Jun 4, 2020 | Initial | $3,032,514 | No comparison | 38 | SEC filing |
| May 18, 2020 | Initial | $209,488 | No comparison | 15 | SEC filing |
| May 14, 2020 | Initial | $268,061 | No comparison | 6 | SEC filing |
| Nov 10, 2016 | Initial | $35,000 | No comparison | 1 | SEC filing |
| Jun 8, 2015 | Initial | $95,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-542862
Source: Form D, filed Apr 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Manish Bhandari | Director |
| Elazer Edelman | Director |
| John Edwards | Director |
| Laura Indolfi | Director, Executive |
| D Mackey | Director |
| Maria Palasis | Director |
| David Ting | Director |
| Daniel Wildman | Director |
| Darshana Zaveri | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7000 Bee Caves Road Suite 300
Austin, TX, 78746
Austin, TX, 78746